In the current trading session, Applied Therapeutics Inc’s (APLT) stock is trading at the price of $1.71, a fall of -2.57% over last night’s close. So, the stock is trading at a price that is -83.95% less than its 52-week high of $10.62 and 1.49% better than its 52-week low of $1.68. Based on the past 30-day period, the stock price is -83.91% below the high and +2.36% above the low.
The 200-day Simple moving average is often placed more emphasis on by traders because of daily price changes. Investors will use the SMA-200 in different situations in trading activity as a key indicator to determine their support and resistance levels, and at the moment, APLT’s SMA-200 is $6.1679.
It is also essential to consider APLT stock ratios like the price-to-sales ratio, which is 18.61 for the last year.APLT’s price to book ratio for the most recent quarter was 33.67, resulting in an 2.01 price to cash per share for the period.
How does Applied Therapeutics Inc (APLT) stock rate among analysts? Buy, sell, or hold?
The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. Currently, there are 6 brokerage firms that recommend the stock as a Strong Buy. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1. Using a scale of 1-5, the current average recommendation is 4.33 in simple terms.
Applied Therapeutics Inc (APLT): Earnings History
Most analysts expect public companies to report earnings and revenue in line with their projections, but sometimes these figures vary from what they actually expected. In the current quarter, the company had earnings predictions made by 1 different analysts, who are expecting earnings to fall in between the range of -0.21 and -0.21 with an average Earnings Estimate of -0.21 which is in contrast with the last year earnings estimate of -0.33 and also replicates 36.36% growth rate year over year.
Applied Therapeutics Inc (NASDAQ: APLT) Ownership Details
I will give a breakdown of the key shareholders in Applied Therapeutics Inc (APLT). Recent figures show that the company’s insiders hold 5.24% of shares. A total of 168 institutional investors hold shares in the company, making 101.89% of its stock and 107.53% of its float.
Sep 30, 2024, it was reported that the Company’s largest institutional holder is Janus Henderson Group PLC holding total of 10.54 shares that make 9.06% of the company’s total number of shares and are currently priced at 18.03 million.
The securities firm Morgan Stanley holds 9.9 shares of APLT, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 8.51%, and the holding percentage of shares is valued at 16.94 million.
An overview of Applied Therapeutics Inc’s technicals
In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests Applied Therapeutics Inc (APLT) traded 6,254,519 shares per day, with a moving average of $8.2817 and price change of -7.5506. With the moving average of $8.4512 and a price change of -5.9706, about 3,603,565 shares changed hands on average over the past 50 days. Finally, APLT’s 100-day average volume is 3,067,466 shares, alongside a moving average of $7.1418 and a price change of -3.8406.
